Tumour necrotizing factor-α promoter and GST-T1 genotype predict skin allergy to chromate in cement workers in Taiwan

Contact Dermatitis

Volumn 57, Issue 5, 2007, Pages 309-315

  Wang Jr , Bour ^a   Shiao, Judith Sc ^b   Chen, Chiou Jong ^c   Lee, Yeu Chin ^d   Guo, Yue Liang ^d,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Institute of Occupational Safety and Health   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cement workers; Chromate sensitivity; Contact dermatitis; Occupational dermatitis; Transepidermal water loss

Indexed keywords

ADENINE NUCLEOTIDE; CEMENT; CHROMIC ACID; GLUTATHIONE TRANSFERASE T1; GUANINE NUCLEOTIDE; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONFIDENCE INTERVAL; CONTACT DERMATITIS; CONTACT SENSITIZATION; DISEASE PREDISPOSITION; ENZYME ASSAY; FEMALE; GENOTYPE; HUMAN; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ECZEMA; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; SKIN ALLERGY; TAIWAN; TELEPHONE;

ADULT; AGED; ALLERGENS; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATES; CONSTRUCTION MATERIALS; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, OCCUPATIONAL; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; POLYMERASE CHAIN REACTION; QUESTIONNAIRES; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35248878693     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2007.01242.x     Document Type: Article

References (60)

1. Denton C R, Keenan R G, Birmingham D J. The chromium content of cement and its significance in cement dermatitis. J Invest Dermatol 1954: 23: 189 192.
2. Coenraads P J, Nater J P, Jansen H A, Lantinga H. Prevalence of eczema and other dermatoses of the hands and forearms in construction workers in the Netherlands. Clin Exp Dermatol 1984: 9: 149 158.
3. Rycroft R J G. Acute ulcerative contact dermatitis from ready-mixed cement. Clin Exp Dermatol 1980: 5: 245 247.
4. Fisher A A. Cement burns resulting in necrotic ulcers due to knelling. Cutis 1979: 23: 272 274.
5. Pirila V. On role of chrome and other trace elements in cement eczema. Acta Dermatol-Venereol (Stockh) 1954: 34: 136.
6. Calnan C D. Cement dermatitis. J Occup Med 1960: 2: 15 22.
7. Kimber I, Cumberbatch M, Dearman R J, Bhushan M, Griffiths C E. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000: 142: 401 412.
8. Howard T D, Meyers D A, Bleecker E R. Mapping susceptibility genes for asthma and allergy. J Allergy Clin Immunol 2000: 105: S477 S4481.
9. Westphal G A, Schnuch A, Moessner R, Konig I R, Kranke B, Hallier E, Ziegler A, Reich K. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003: 48: 93 98.
10. Geha R S. Regulation of IgE synthesis in humans. J Allergy Clin Immunol 1992: 90: 143 150.
11. Rosenwaser L J, Klemm D J, Dresback J K et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995: 25: 74 78.
12. Zhu S, Chan-Yeung M, Becker A B et al. Polymorphisms of the IL-4, TNF-α, and FcεRI-β genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000: 161: 1655 1659.
13. Rosenwasser L J, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997: 156: S152 S155.
14. Mali J W H, Van Kooten W J, Van Neer F C J, Spruit D. Quanitative aspects of chromium sensitization. Acta Dermatovenereol (Stockh) 1964: 44: 44 48.
15. Samitz M H, Katz S, Scheinern D M, Gross P R. Chromium-protein interaction. Acta Derm Venereol (Stockh) 1969: 49: 142 146.
16. Shelly W B, Juhlin L. Langerhans cells form a reticuloepithelial trap for external contact antigens. Nature 1976: 261: 46 47.
17. Arslan P, Beltrame M, Tomasi A. Intrcellular chromium reduction. Biochimica et Biophysica Acta 1987: 931: 10 15.
18. Evans W E. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999: 286: 487 491.
19. Seidegard J, Relling M V, Pero R W, Miller D G, Beattie E J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986: 7: 751 753.
20. Pemble S, Schroder K R, Spencer S R, Meyer D J, Hallier E, Bolt H M, Ketterer B, Taylor J B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994: 300: 271 276.
21. Alexandrie A K, Sundberg M I, Seidegard J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in rlation to age at onset, gender and histological cancer types. Carcinogenesis 1994: 15: 1785 1790.
22. Anttila S, Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994: 15: 1133 1135.
23. d'Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarker 1996: 1: 149 173.
24. Wang X, Zuckerman B, Pearson C et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002: 287: 195 200.
25. Guo Y L, Wang B J, Wang J C, Yeh K C, Kao H H, Wang M T, Shih H C, Chen C J. Skin diseases in cement workers in Southern Taiwan. Contact Dermatitis 1999: 40: 1 7.
26. Wahlberg J E. Patch testing. In: Textbook of Contact Dermatitis, Rycroft R J G et al eds Springer-Verlag, Berlin, 1992: pp. 239 268.
27. Walley A J, Cookson W O. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996: 33: 689 692.
28. Albuquerque R V, Hayden C M, Palmer L J et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998: 28: 578 584.
29. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996: 236: 184 186.
30. Vahter M, Berglund M, Akesson A, Liden C. Metals and women's health. Environ Res 2002: 88: 144 155.
31. Avnstorp C. Follow-up of workers from the prefabricated concrete industry after the addition of ferrous sulphate to Danish cement. Contact Dermatitis 1989: 20: 365 371.
32. Enk A H, Angeloni V L, Udey M C, Katz S I. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 1993: 150: 3698 3704.
33. Steinman R M, Hoffman L, Pope M. Maturation and migration of cutaneous dendritic cells. J Invest Dermatol 1995: 105: 2S 7S.
34. Wang B H, Amerio P, Sauder D N. Role of cytokines in epidermal Langerhans cell migration. J Leukoc Biol 1999: 66: 33 39.
35. Piguet P F, Grau G E, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 1991: 173: 673 679.
36. Lisby S, Muller K M, Jongeneel C V, Saurat J H, Hauser C. Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Int Immunol 1995: 7: 343 352.
37. Smith H R, Basketter D A, Mcfadden J P. Irritant dermatitis, irritancy, and it role in allergic contact dermatitis. Clincial and Experimental dermatology 2002: 27: 138 146.
38. Winder C, Carmody M. The dermal toxicity of cement. Toxicology and industrial health 2002: 18: 321 331.
39. Burrows D. Adverse chromate reactions on the skin. In: "Chromium: metabolism and toxicity", Burrow D (ed Boca Raton Florida, CRC press, 1983: pp. 137 163.
40. Avnstorp C. Cement eczema. An epidemiological intervention study. Acta Derm Venereol Suppl (Stockh) 1992: 179: 1 22.
41. Wilson A G, Symons J A, McDowell T L, McDevitt H O, Duff G W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Nat Acad Sci U S A 1997: 94: 3195 3199.
42. Kroeger K M, Carville K S, Abraham L J. The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997: 34: 391 399.
43. Bouma G, Crusius J B, Oudkerk Pool M et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996: 43: 456 463.
44. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998: 113: 401 406.
45. Allen M H, Wakelin S H, Holloway D, Lisby S, Baadsgaard O, Barker J N, McFadden J P. Association of TNFA gene polymorphism at position-308 with susceptibility to irritant contact dermatitis. Immunogenetics 2000: 51: 201 205.
46. Rowe A, Bunker C B. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Dermatitis 1998: 38: 36 39.
47. Asherson G L, Dieli F, Sireci G, Salerno A. Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 1996: 103: 1 4.
48. Seidegard J, Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 1997: 105: 791 799.
49. Fuchs J, Zollner T M, Kaufmann R, Podda M. Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 2001: 30: 337 353.
50. Standeven A M, Wetterhahn K E. Is There a Role for Reactive Oxygen Species in the Mechanism of Chromium (VI) Carcinogenesis? Chem Res Toxicol 1991: 4: 616 625.
51. Miyachi Y, Uchida K, Komura J, Asada Y, Niwa Y. Auto oxidative damage in cement dermatitis. Arch Dermatol Res 1985: 277: 288 292.
52. Wolber R, Staeb F, Abeck D, Bleck O, Schreiner V, Untiedt S, Sauermann G, Hoppe U. Antioxidant status and role of oxidative stress in atopic dermaitits. J Invest Dermatol 1996: 106: 888.
53. Pereira P, Rocha R L, Santos-Silva A, Figueiredo A, Ferra M I A, Quintanilha A, Teixeira F. Leukocyte activation and oxidative stress in psoriasis. Br J Pharmacol 1999: 127: 83.
54. Bauerle P A, Henkel T. Function and activation of NFkB in the immune system. Annu Rev Immunol 1994: 12: 141 179.
55. Sen C K, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996: 10: 709 720.
56. Rutault K, Alderman C, Chain B M, Katz D R. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 1999: 26: 232 238.
57. Sharkey P, Eedy D J, Burrows D, McCaigue M D, Bell A L. A possible role for superoxide production in the pathogenesis of contact dermatitis. Acta Derm Venereol (Stockh) 1991: 71: 156 159.
58. Hayes J D, Strange R C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000: 61: 154 166.
59. Holla L I, Stejskalova A, Vasku A. Polymorphisms of the GSTM1 and GSTT1 genes in patients with allergic diseases in the Czech population. Allergy 2006: 61: 265 267.
60. Strange R C, Lear J T, Fryer A A. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact 1998: 111-112: 351 364.